NSUP
AMRX icon

NLB Skladi upravljanje premozenja’s Amneal Pharmaceuticals AMRX Stock Holding History

NLB Skladi upravljanje premozenja’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.43M Buy
115,000
+15,000
+15% +$201K 0.07% 185
2025
Q4 		$1.26M Buy
+100,000
New +$1.14M 0.06% 201

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

NLB Skladi upravljanje premozenja's AMRX Position: Q1 2026 in Review

NLB Skladi upravljanje premozenja increased its Amneal Pharmaceuticals (AMRX) stake by 15% in Q1 2026, buying an estimated $201K and bringing the position to 115,000 shares worth $1.43M. The position accounts for 0.07% of the portfolio, ranked #185.

NLB Skladi upravljanje premozenja first reported a position in AMRX in Q4 2025 and has held it in 2 quarters since. 316 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • NLB Skladi upravljanje premozenja held 115,000 shares of Amneal Pharmaceuticals worth $1.43M as of Q1 2026.
  • NLB Skladi upravljanje premozenja bought 15,000 Amneal Pharmaceuticals shares in Q1 2026, an estimated $201K.
  • Amneal Pharmaceuticals made up 0.07% of NLB Skladi upravljanje premozenja's portfolio in Q1 2026, its #185 holding.
  • NLB Skladi upravljanje premozenja first reported a position in Amneal Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 316 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on NLB Skladi upravljanje premozenja's 13F filing for Q1 2026, filed 11 May 2026.